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HIV, Stigma, and Rates of Infection: 
More Complicated than Reidpath 
and Chan Suggest
Sam Singer
In their essay in October’s PLoS Medicine, Daniel Reidpath 
and Kit Yee Chan challenge the widely cited link between 
HIV-related stigma and the spread of the epidemic [1]. 
This is an important question, given the heavy emphasis on 
stigma in policies of the World Health Organization, the Joint 
United Programme on HIV/AIDS, and other public health 
institutions, but in making their argument Reidpath and 
Chan misrepresent the connections that other authors have 
made between stigma and viral transmission, ignore evidence 
that does suggest an association, and propose a model of their 
own for which they offer no evidence.
HIV infection establishes itself ﬁ rst in certain high-risk 
groups—men who have sex with men, intravenous drug 
users, sex workers, mobile populations—and only later 
moves into the general population. In the early stages of the 
epidemic, stigma facilitates transmission within high-risk 
groups, because these already marginalized groups receive 
little attention from policy makers and the health-care 
community and are further discriminated against when they 
are identiﬁ ed with HIV and AIDS [2]. Stigma also prevents 
or makes it more difﬁ cult for members of high-risk groups 
to access preventive services, including HIV antibody testing 
[3]. Reidpath and Chan distort this dynamic by describing 
a model in which stigma leads to fear which leads to unsafe 
behavior. We know of no one who suggests that stigma causes 
sex between men or intravenous drug use. Instead, there is 
evidence that HIV-related stigma makes it difﬁ cult for people 
to take actions to reduce their risks; for example, by accessing 
HIV education [4], exchanging needles [5], and negotiating 
condom use [6]. Stigma may even lead women who know 
they are HIV positive to breast-feed their infants rather than 
arouse suspicion of their serostatus through formula feeding 
[7]. This undoubtedly increases the risk of vertical viral 
transmission. 
Reidpath and Chan go on to propose that stigma may 
actually “slow the spread of infection from those [high-
risk] groups to the general population.” Although there 
is a plausible logic to this suggestion, there is no evidence 
for it. Even if stigma does reduce the opportunities that 
marginalized groups have to transmit HIV to the broader 
population, this would have little effect on the dynamics of a 
generalized epidemic. 
While they recognize that stigma presents a barrier to 
the treatment and care of people living with HIV, Reidpath 
and Chan fail to recognize the association this may have 
with increased transmission. HIV-related stigma discourages 
people from disclosing their status, entering care, and 
adhering to antiretroviral regimens, all of which represent 
missed opportunities for prevention. 
Around the world HIV capitalizes on and reinforces social 
stigma and discrimination, especially the low status of women. 
Defeating the epidemic requires an honest examination of all 
these phenomena and interventions that target both the virus 
itself and its widespread social impacts. 
Sam Singer (ssinger@berkeley.edu)
Joint Medical Program
University of California Berkeley—University of California San Francisco
San Francisco, California, United States of America
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HIV, Stigma, and Rates of Infection: 
A Human Rights and Public Health 
Imperative
Susan Timberlake, Jason Sigurdson
In their essay “HIV, Stigma, and Rates of Infection: A Rumour 
without Evidence”, Daniel Reidpath and Kit Yee Chan 
rightly underscore the insufﬁ cient body of research on the 
relationship between stigma and discrimination and HIV 
transmission [1]. Increased scientiﬁ c attention and effective 
programming against stigma and discrimination are both 
sorely needed. But the Joint United Nations Programme on 
HIV/AIDS (UNAIDS) does not accept a number of points 
made in the essay.
Discrimination based on health status, including HIV, is a 
human rights violation, and stigma is the social form of this 
violation. HIV stigma and discrimination are wrong in and 
of themselves, and should be stopped for that reason alone. 
Reidpath and Chan suggest, as “an alternative hypothesis to 
the UNAIDS position”, that stigma against certain groups, 
including people living with HIV, may have a public health 
value because it “could reduce opportunities for contact 
between high- and low-risk groups”. UNAIDS cannot endorse 
a hypothesis that bases a public health goal on a human rights 
violation; nor do we believe it is either right, or necessary, to 
pit the public health against human rights.
The right to health—and human value, dignity, and 
autonomy, the bases of human rights—requires that people 
PLoS Medicine  |  www.plosmedicine.org 0191
have the information, services, and support they need to 
protect their health and avoid causing harm to others. So 
does the public health. In this context, people living with HIV 
should not and need not be social pariahs to achieve public 
health goals; neither should HIV-negative people be put in 
a position of “protecting themselves” through stigma against 
others.
UNAIDS stands by the view that stigma and discrimination 
increase vulnerability to both infection and the impact of 
HIV. People, including those living with HIV, repeatedly 
make clear that their fear, or real experience, of stigma and 
discrimination affects whether, when, and how they take up 
HIV prevention and treatment goods and services. Thus, 
efforts to get people to protect themselves from getting 
infected, or if infected, to ﬁ nd out about their status, prevent 
the onward transmission of HIV, and access treatment, are 
hindered by stigma and discrimination.
UNAIDS encourages both governments and researchers 
to focus on what Reidpath and Chan consider “the more-
difﬁ cult issues relating to the manner in which HIV spreads 
in populations, the social vulnerabilities it exploits, and the 
ways in which individuals…interact with each other”. But 
the complexities the authors cite undermine their argument 
that stigma between groups may result in a reduction of HIV 
transmission. In dealing with HIV, it has become very clear that 
people’s behaviour transcends population groups over time 
and space. The belief that risk rests in “the other” creates a 
false perception of safety and may in fact increase vulnerability.
Stigma and discrimination by governments against 
particular groups, such as women, the poor, sex workers, 
ethnic minorities, people who use drugs, migrants, men 
who have sex with men, and prisoners, often means that 
those most affected by HIV receive the least attention in the 
response. This makes the national HIV response less effective 
and compounds human rights violations against these people.
Contrary to the authors’ assertion that the link between 
stigma and the epidemic has “become the basis for 
considerable policy and program development”, very little in 
fact is being done about stigma and discrimination in national 
programmatic responses. This is cause for great concern, 
given that stigma and discrimination have been identiﬁ ed as 
major barriers to achieving universal access to prevention, 
treatment, care, and support in all the consultations on the 
subject. Will governments ﬁ nally implement programmatic 
responses to overcome stigma and discrimination? We believe 
it is essential that they do so.
As the number of infections increase and millions still need 
treatment, UNAIDS welcomes the growing body of research 
on HIV stigma and discrimination. Among other things, we 
are supporting people living with HIV to develop an index on 
stigma and discrimination. We hope that data from this tool 
will both provoke and assist governments to overcome stigma 
and discrimination in their national responses to HIV. People 
and governments confronting HIV should do so not out of 
fear or stigma, but out of the knowledge that we all share the 
same rights and protecting these rights protects us all from 
HIV and AIDS. 
Susan Timberlake (timberlakes@unaids.org)
Jason Sigurdson
Joint United Nations Programme on HIV/AIDS 
Geneva, Switzerland
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HIV, Stigma, and Rates of Infection: 
But Is AIDS-Related Stigma Understood?
Arachu Castro
Although its title attracted me to read this paper [1], I 
was quickly disappointed. First, it advances a Malthusian 
approach that applauds the “potential beneﬁ ts” of AIDS-
related stigma. Second, it reﬂ ects a poor understanding of 
some of the existing literature on AIDS-related stigma cited 
in the article. The authors claim that the idea that stigma 
and discrimination thwart efforts to control the epidemic 
and constitute barriers for prevention and treatment is 
said over and over, with no evidence, “like a shibboleth,” 
and cite eleven references that are meant as examples 
of this uncritical repetition. Surprisingly though, at least 
one of the articles cited already argues that “confusion 
surrounds debate over stigma as a barrier to introducing 
antiretrovirals to poor countries or to making voluntary HIV 
tests accessible” and that “to assess AIDS-related stigma and 
declare it a cause rather than both cause and consequence 
of inequality will probably weaken efforts to address AIDS 
among those with heightened risk of HIV because of poverty, 
racism, and gender inequality” [2]. Finally, the authors 
show limited understanding of social and sexual dynamics. 
Their distinction between “subpopulations” and “the general 
population” seems to imply that the former, such as the 
subpopulation of sex workers, lives in isolation of the latter 
and that it takes a certain amount of time for HIV to go from 
one to the other; it implies, for example, that sex workers 
ﬁ rst transmit HIV amongst themselves and then at some 
later point they transmit it to “the general population.” I 
am afraid that the authors are actually conceptualizing HIV 
transmission within the similar linear frameworks that they 
are trying, unsuccessfully, to criticize. 
Arachu Castro (Arachu_Castro@hms.harvard.edu)
Harvard Medical School
Boston, Massachusetts, United States of America
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HIV, Stigma, and Rates of Infection: 
Absence of Evidence
Mark Seielstad
Absence of evidence is not evidence of absence. Reidpath and 
Chan [1] present absolutely no reasons or data that would 
undermine the hypothesis that stigmatization can increase 
the risk of HIV spread in populations (nor any in favor of 
their own contrary hypothesis that stigmatization could halt 
the spread of HIV). More data to address the question may be 
needed to establish either hypothesis, but motivations to collect 
such data should not come from illogical and inﬂ ammatory 
counterhypotheses. In the guidelines for correspondence 
to PLoS Medicine, we are advised that “...letters inciting racial 
hatred, sexism, or homophobia [will not be published]” [2], 
but the present authors skirt the commission of such acts 
very closely. After all, HIV prevalences also differ among 
races, sexes, and sexual orientations, so the stigmatization of 
groups with high rates of infection by those with lower rates 
of infection could be viewed as helpful to the goal of HIV 
containment. This seems unlikely to be helpful, and would 
impose a much greater societal cost. This essay is shameful in 
its intellectual dishonesty and lack of evidence to support its 
own unappealing counterhypothesis. 
Mark Seielstad (mseielst@hsph.harvard.edu)
Harvard School of Public Health
Boston, Massachusetts, United States of America
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HIV, Stigma, and Rates of Infection: 
A Rumour without Evidence: Authors’ Reply
The HIV/AIDS area has always been highly politically 
and emotionally charged, and we wrote a controversial 
and provocative piece. Most of the responses to it were 
unreasoned. The most cogent response came from UNAIDS 
(the Joint United Nations Programme on HIV/AIDS) [1], 
and it generally restated an already well articulated position. 
We disagree with a number of the points for the reasons 
discussed in our original essay, and applaud one point.
First, a brief restatement of our argument is warranted. 
There is good evidence that HIV-related stigma adversely 
affects the lives of people living with HIV/AIDS. There is little 
or no evidence, however, to support the notion that HIV-
related stigma is one of the determinants of the global HIV 
epidemic. Furthermore, an argument could be made for why 
stigma might slow or contain the spread of infection in the 
general population. Given the very different effect the two 
positions would have on policy and the signiﬁ cance of the HIV 
epidemic, they deserve investigation. Among epidemiologists, 
two competing hypotheses, for which there is no strong 
evidence either way, would constitute a position of equipoise.
The UNAIDS position is that HIV stigma and discrimination 
is a human rights violation “and should be stopped for 
that reason alone” [1]. Excellent point! Let’s do that and 
understand why we are doing it. But in the absence of evidence, 
do not let us conﬂ ate the epidemiology of the infection with 
the human rights position. The letter goes on to say that 
“UNAIDS cannot endorse a hypothesis that….” Of course, 
we never wanted a hypothesis endorsed. We want hypotheses 
tested. The original (UNAIDS) position is treated as fact, and 
from the UNAIDS response, continues to be treated as a fact, 
when it was (and is) simply a hypothesis. Before this or any 
other hypothesis is endorsed, it should be tested.
The role of stigma is complex, carrying with it social 
beneﬁ ts and social harms. It is a social process. By treating 
it as a serious object of health research, its multiple roles, 
including its role in disease propagation, can be legitimately 
investigated rather than marginalized as the poster child 
of advocates. Furthermore, by understanding the nature of 
stigma, it may be possible to develop health interventions 
that neither rely on stigma to succeed nor arbitrarily and 
inappropriately declare it to be a causal agent.
Research and advocacy have important and fundamental 
roles in population health. They each need to be used 
appropriately. 
Daniel D. Reidpath (daniel.reidpath@brunel.ac.uk)
Brunel University
Uxbridge, Middlesex, United Kingdom
Kit Yee Chan
Deakin University
Burwood, Victoria, Australia
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Noncommunicable Diseases 
and Injuries: Action Needed 
in South Asia Too
Ali Khan Khuwaja, Riaz Qureshi, Zafar Fatmi
We read with great interest the essay by Perel et al. [1] on 
noncommunicable diseases (NCDs) and injuries in Latin 
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America and the Caribbean (LAC) countries. The authors 
are to be congratulated for their excellent description of 
the epidemic of NCDs and injuries in the LAC region. We 
wish to comment on this growing epidemic of NCDs with 
reference to South Asian (SA) countries, where the situation 
is comparable to the LAC region. 
South Asia, which has one quarter of the world’s 
population, is experiencing a rapid epidemiological transition 
similar to the LAC countries. The rising epidemic of NCDs 
in the SA region is fuelled by demographic ageing and 
globalization resulting in changing lifestyle, eating habits, and 
working patterns with less physical activity. 
In 2000, 44% of the burden of disease in this region 
measured in disability-adjusted life years (DALYs) lost was 
attributed to NCDs [2], and these ﬁ gures are expected to rise. 
Yet this growing epidemic is a neglected health issue in these 
countries to a greater extent. Cardiovascular diseases are the 
major contributors to premature mortality and morbidity in 
the SA region. The prevalence of diabetes has risen more 
rapidly in South Asia than in any region of the world. By the 
year 2030, India will have the highest number of persons with 
diabetes (79.4 million) [3]; similar trends are also projected 
for other SA countries. Overall, prevalence of hypertension 
among Pakistani adults (greater than or equal to 15 years) is 
about 19% [4], and this is likely to be the pattern in other SA 
countries. In South Asia, one third of the adult population 
is classiﬁ ed as obese and the trend is also increasing in SA 
children [5,6]. Large numbers of South Asians use tobacco 
in various forms: it is estimated that up to 65% of all men 
use tobacco in some form [7]. Tobacco use is responsible 
for approximately half of the tumors in males [8]. South 
Asians have one of the highest rates of oral cancers reported 
worldwide, and the rates are still increasing [7,8]. Due to 
the lack of reliable data and under-reporting of injuries, it is 
difﬁ cult to estimate their prevalence and future projections; 
nevertheless, the burden is substantially high enough to be 
one of the major health concerns in South Asia. In Sri Lanka 
alone, a smaller SA country, road trafﬁ c injuries result in 
2,000 deaths and 14,000 injuries each year [9]. 
NCDs are expensive diseases to manage, and SA countries, 
which already have poor health and economic indicators, 
cannot afford this emerging costly epidemic. South Asians 
have a tendency to develop cardiovascular diseases at 
relatively earlier ages compared to other parts of the world, 
resulting in the highest potential of loss of productive life 
years. For a low-income Indian family with an adult with 
diabetes, as much as 25% of family income may be devoted to 
diabetes care [10]. 
Like the LAC region [1], SA countries have social and 
cultural disparities and inequalities. People of higher 
socioeconomic status and men who are the major economic 
contributors of their families are usually able to access the 
best available health-care facilities. As in LAC countries, 
South Asians of lower socioeconomic levels have the highest 
prevalence of mental health problems. The SA countries are 
well-equipped with highly qualiﬁ ed human resources and 
have common culture and languages, which can enhance 
more meaningful research, but are often unable to produce 
signiﬁ cant levels of quality research due to lack of funding 
and ﬁ nancial resources. With some exceptions, much of the 
research on NCDs has been descriptive or observation and on 
a small scale. Hence, the generalizability of existing research 
for the whole region is questionable and translating this 
research into practice is also difﬁ cult. 
Keeping in mind the frightening scenario of NCDs in SA 
countries, the best option to tackle the epidemic is to take 
earlier action through comprehensive, multifaceted, and 
multicultural preventive and interventional strategies. There 
is also a need for more population-based local research 
on NCDs, with more collaboration and networking. These 
all require innovation, funding, political will, and health 
partnership between individuals, communities, clinicians, 
public health practitioners, nongovernmental agencies, policy 
makers and governments of the SA region. 
Ali Khan Khuwaja (ali.khuwaja@aku.edu)
Riaz Qureshi
Zafar Fatmi
Aga Khan University
Karachi, Pakistan
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Eight Americas: Differences in Asian 
Communities Are Important
Linda Silka, Robin Toof, Dorcas Grigg-Saito
The article “Eight Americas: Investigating Mortality 
Disparities across Races, Counties, and Race-Counties in the 
United States” [1] reports on what the authors describe as 
racial differences in mortality. The authors analyze what they 
label the “eight Americas” (i.e., Asian; Northland low-income 
rural white; Middle America; low-income whites in Appalachia 
and the Mississippi Valley; Western Native American; Black 
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Middle America; Southern low-income rural black; high-risk 
urban black). In contrast to other races, “Asian” is treated 
as a single homogenous category. Income and geographical 
differences are not considered. The authors point out that 
they have likely collapsed across differences with the “Asian” 
category, but they go on to report their results as if such 
differences are inconsequential. They are not. With regard to 
health disparities, such differences are particularly important. 
Consider recent ﬁ ndings that speak to health differences 
within the nominal category of “Asian.” As a part of the 
Center for Disease Control and Prevention’s Racial and 
Ethnic Approaches to Community Health (REACH) 2010 
program [2], a survey was conducted in 2001–2002 with a 
sample of Vietnamese in several counties in California and 
Cambodians in Lowell, Massachusetts (the second largest 
Cambodian community in the US). Comparing the results to 
the national 2002 Behavior Risk Factor Surveillance System 
survey that aggregates all Asian responses, the Koch-Weser 
et al. data indicate that the educational level and income of 
Cambodians and Vietnamese were substantially lower than 
all Asians, and that Cambodians and Vietnamese were three 
times more likely than other Asians to not have visited a 
doctor in the past year due to ﬁ nancial reasons. In addition, 
in comparison to all Asians or the general population, higher 
proportions of Cambodian and Vietnamese men reported 
smoking (50.4% and 30.4% respectively compared to 14.7% of 
aggregated Asians), and Cambodian and Vietnamese of both 
genders reported eating fewer vegetables (16.4% and 11.1%). 
And in the case of important chronic health problems such 
as diabetes, only 47.7% of Cambodians surveyed reported 
having their cholesterol checked and 41.9% reported having a 
hemoglobin A1c test conducted if they had diabetes. 
A 2002 representative survey of Cambodian adults over age 
25 in Lowell, Massachusetts [3] found that Cambodians were 
more likely to report poor health than other Massachusetts 
residents (9% compared to 2%). Cambodian women and 
elders were much more likely to have experienced days of 
poor physical health (6.5 days on average for women and 
8 days those over 50). A quarter of the Cambodian elders 
were symptomatic for depression, with the rate rising to 43% 
among women 50 and over. Although only 6% reported 
being uninsured, 23% wanted to see a doctor in the last year 
but could not, and 44% did not because of transportation 
problems. 
In short, existing ﬁ ndings indicate how diverse the health 
data can be within the overall category of “Asian.” The 
authors are to be applauded for their recognition of how 
misleading it can be to treat the categories of “blackness” or 
“whiteness” in undifferentiated ways. Unfortunately they have 
failed to extend that same understanding to the analysis they 
select for the category of Asians. As researchers and policy 
makers use the “Eight Americas” study to guide their efforts, 
the result could well be misleading interpretations that do 
a disservice to those very groups within the “Asian” category 
who face daily struggles with signiﬁ cant health problems and 
poor access to health care. 
Linda Silka (linda_silka@uml.edu)
University of Massachusetts Lowell
Lowell, Massachusetts, United States of America
Robin Toof
Center for Family, Work, and Community
University of Massachusetts Lowell
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Eight Americas: A New Deﬁ nition 
for “Americas”?
Howard Junca
The use of the term “Americas” in the context of this 
article [1] could confuse or mislead readers from a global 
audience. The authors used this term to refer to an artiﬁ cial 
classiﬁ cation of United States (American) populations 
based on sociological aspects in order to group and analyse 
epidemiological information, but, Americas (plural and 
generally with the deﬁ nite article) does not mean such 
division inside America (the United States of America in 
this case), but refers to the lands and regions of the Western 
hemisphere (North America, Central (or Middle) America, 
and South America, including their associated islands and 
regions). While it is clear that the usage of this term in the 
article is not the one strictly established, e.g., for legal issues, 
but instead is a part of a conceptual framework, I respectfully 
consider that the usage of the term “Americas” in the title of 
this article, as in other essential parts of the publication, is 
imprecise and contradictory. 
Howard Junca (howard.junca@helmholtz-hzi.de)
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HIV and Cardiovascular Disease: 
Contribution of HIV-Infected 
Macrophages to Development 
of Atherosclerosis
Michael Bukrinsky, Dmitri Sviridov
In their Perspective published in PLoS Medicine [1], Carr 
and Ory provide a fair review of our recent paper in PLoS 
Biology [2]. However, we believe their commentary puts too 
much emphasis on the role of low high-density lipoprotein 
(HDL) cholesterol levels as a cause of atherosclerosis in 
HIV-infected patients. While HDL cholesterol levels are 
reduced in untreated HIV infection [3], and defects in 
reverse cholesterol transport (RCT) that we reported may 
well be a contributing factor to this abnormality, initiation of 
antiretroviral therapy restores HDL levels [4]. Although the 
development of dyslipidemia with prolonged use of anti-HIV 
drugs again lowers HDL cholesterol and in addition raises 
very low-density lipoprotein and low-density lipoprotein levels 
[5], it is unlikely that HIV infection contributes signiﬁ cantly 
to these effects. Indeed, most HDL comes from the liver 
and intestine, which are responsible for maintaining plasma 
HDL levels [6], but neither hepatocytes nor enterocytes are 
infected by HIV. Also, the number of HIV-infected cells in 
treated patients is relatively low to account for any general 
changes in concentration of plasma lipoproteins. 
We suggest a different model that provides a simple 
connection between HIV-induced impairment of the 
cellular step of RCT and pathogenesis of atherosclerosis. 
We propose that RCT-defective HIV-infected macrophages 
contribute to development of atherosclerosis in HIV patients 
by converting into foam cells and initiating plaque formation 
in the vessel wall. Indeed, speciﬁ c inactivation of ABCA1 in 
macrophages has been shown to induce atherosclerosis in 
a mouse model independently from plasma HDL level [7]. 
Plaque formation through this mechanism can begin even 
on the background of normal HDL but would be greatly 
accelerated by dyslipidemia, a condition observed in HIV 
patients treated with antiretroviral therapy. Given that even 
fully suppressive HAART (highly active antiretroviral therapy) 
does not eliminate long-lived productive reservoirs of the 
virus and that macrophages are a likely potential component 
of these reservoirs [8], long-lived HIV-infected macrophages 
may contribute to atherosclerotic plaque formation long 
after initiation of HAART. Consistent with this hypothesis, it 
was found that the majority of cardiovascular events in HIV-
infected patients are “one plaque” events [9]. 
Therefore, several lines of evidence indirectly implicate 
HIV-infected macrophages in the pathogenesis of 
atherosclerosis in HIV patients. Future studies will determine 
the role of HIV-induced RCT impairment in this process and 
are expected to provide an understanding of the connection 
between HIV infection and atherosclerosis and to identify 
novel treatment targets for both diseases. 
Michael Bukrinsky (mtmmib@gwumc.edu)
George Washington University
Washington, District of Columbia, United States of America
Dmitri Sviridov
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Mental Health in the Millennium 
Development Goals: Not Ignored
Sonia Ehrlich Sachs, Jeffrey D. Sachs
In a PloS Medicine article of September 2005, J. Jaime Miranda 
and Vikram Patel ask: “Achieving the Millennium Development 
Goals [MDGs]: Does Mental Health Play a Role?” [1]. We agree 
with their concern that “there is no health without mental 
health.” However, we do not feel mental health is ignored in 
the health agenda, nor do we share their pessimism about the 
potential to reach the MDGs in general.
Skepticism about the success of the MDGs is based on 
the poor track record of past international goals such as the 
Universal Declaration of Human Rights or the Declaration of 
Alma-Ata. Indeed, the MDGs were adopted with these pitfalls 
in mind. Emphasis was given to setting bold but realistic 
goals, with quantiﬁ able, time-bound targets. For example, 
the aim to “reduce by two-thirds, between 1990 and 2015, 
the under-ﬁ ve mortality rate,” calls for a practical plan with 
concrete, monitorable guideposts.
Many assessments have shown how these health goals can 
be achieved over the next ten years. The fact that progress 
on under-5 mortality and disease control has been too slow 
and that previous goals have not been met is why the world 
needs the MDGs. Without these targets that hold poor and 
rich countries accountable, poor countries will miss the 
benchmarks laid out in the Millennium Declaration, even 
though the objectives are attainable.
The reason that the MDGs do not explicitly address 
noncommunicable diseases such as cardiovascular or 
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psychiatric diseases is that the MDGs focus on the gap in 
health status between rich and poor countries, a gap mainly 
accounted for by infectious diseases, malnutrition, and unsafe 
childbirth. The goals were crafted to address these large gaps 
rather than to solve all pressing health problems.
We agree that “mental illness is closely associated 
with social determinants, notably poverty and gender 
disadvantage, and with poor physical health, including 
having HIV/AIDS and poor maternal and child health.” 
About 2.6% of disability-adjusted life years in sub-Saharan 
Africa are attributable to psychiatric conditions, which 
is about the same proportion attributable to nutritional 
deﬁ ciencies, or tuberculosis, or maternal complications 
from childbirth [2]. There are many areas in which 
governments are using MDG-based strategies to tackle 
problems that are not explicitly mentioned by the MDGs, 
such as electriﬁ cation, road construction, increased 
agricultural yields, and more.
The author’s contention that “the MDGs do not address 
strengthening of health systems” is not correct, as readers of 
the UN Millennium Project recommendations (http:⁄⁄www.
unmillenniumproject.org) can see. There is no chance to 
achieve any health MDGs without strengthening the health 
systems. Low-income countries are placing a important 
emphasis on strengthening health systems in their MDG-
based planning. This will provide an important foundation 
for expanded access to critical mental health programs.
The authors question “national ownership” of MDGs and 
therefore question their legitimacy. The MDGs are strongly 
supported throughout the low-income countries, both by 
civil society as well as by governments, many of whom are 
developing MDG-based policies. National ownership was 
vividly displayed in September 2005, when government 
leaders throughout the developing world protested 
vociferously and successfully a short-lived attempt of US 
negotiators to remove the term “Millennium Development 
Goals” from the UN 2005 World Summit agreement.
Columbia University is involved in the Millennium Village 
Project, a proof of concept that the MDGs can be achieved in 
rural Africa by undertaking a holistic approach of integrated 
interventions in increasing food production, improving 
access to health care, water, and education, and improving 
infrastructure. Although the primary focus of health 
intervention is prevention and treatment of the major killers 
such as infectious diseases and malnutrition, we are exploring 
ways to integrate mental health care within the health 
systems, and we welcome practical suggestions for successful 
models that merit replication. The approach focuses on 
community-led development that takes into account social 
determinants of mental disease, as well as accessible mental 
health interventions.
The MDGs are a matter of life and death for millions of 
adults and children. We must do our utmost to ensure their 
success. The development and public health communities—
including mental health professionals—need to work together 
and not undermine the only shared global development goals 
we have. Since their adoption in the year 2000, the MDGs 
have garnered support around the word. If this broad global 
movement continues to gain momentum and to apply proven 
solutions to our most pressing problems, the MDGs can be 
achieved, and with them, so too a signiﬁ cant improvement in 
mental health around the world. 
Sonia Ehrlich Sachs (ssachs@ei.columbia.edu)
Millennium Village Project
Columbia University
New York City, New York, United States of America
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The Earth Institute
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Mental Health in the Millennium Development Goals: 
Authors’ Reply
We appreciate the feedback and responses generated since 
the publication of our paper of September 13, 2005 [1]. 
It clearly fulﬁ ls our aim of initiating a debate around the 
core issue expressed in our work—mainly how the targets 
expressed in the Millennium Development Goals (MDGs) 
may have the unintended consequence of relegating mental 
health and noncommunicable diseases in general from the 
vision of policy makers.
Using evidence on mental health in developing countries, 
we argued in our paper that addressing mental health 
problems is an integral part of health system interventions 
aimed at achieving some of the key MDGs, a view supported 
by the responses to our paper. However, we should clarify that 
within the MDGs there is not a “millennium mental health 
development goal” as suggested by Kasi et al [2].
Sachs and Sachs state that “the reason that the MDGs do 
not explicitly address noncommunicable diseases such as 
cardiovascular or psychiatric is because the MDGs focus on 
the gap in health status of rich and poor countries, a gap 
mainly accounted for by infectious diseases, malnutrition, 
and unsafe childbirth. The goals were crafted to address these 
large gaps rather than to solve all pressing health problems” 
[3]
We think this assertion deserves their reassessment. It is 
a common view to assume that the developing world suffers 
mainly from infectious diseases. In fact, noncommunicable 
diseases kill people at economically and socially productive 
ages and kill them mostly in the developing world: 80% of 
chronic disease deaths occur in low- and middle-income 
countries [4]. Another misconception is that the epidemic of 
noncommunicable diseases is still to come. That is no longer 
true: it is here already [5–7]. We need an informed debate 
about the health interventions needed to tackle the burden 
of disease in the developing world, and one that goes beyond 
the MDGs as they are currently conﬁ gured.
We are delighted to learn that the Sachs are “exploring 
ways to integrate mental health care within the health 
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systems,” and agree that development and public health 
communities—including mental health professionals—need 
to work together to ensure that the MDGs can be achieved. 
Explicitly tackling these mental health gaps, in parallel with 
achieving the existing MDGs, would be a major achievement, 
resulting in signiﬁ cant improvement in mental health around 
the world. 
J. Jaime Miranda (jaime.miranda@lshtm.ac.uk)
Vikram Patel
London School of Hygiene and Tropical Medicine
London, United Kingdom
References
1. Miranda JJ, Patel V (2005) Achieving the Millennium Development Goals: 
Does mental health play a role? PLoS Med 2: e291. doi:10.1371/journal.
pmed.0020291
2. Kasi PM, Naqvi H, Achakzai AM, Gilani AI, Tariq A (2005) Offering a 
sustainable solution to for achieving the “Millennium Mental Health 
Development Goal”: The psychospiritual model. PloS Medicine Reader 
Response. Available: http:⁄⁄medicine.plosjournals.org/perlserv/
?request=read-response&doi=10.1371/journal.pmed.0020291#r941. 
Accessed 29 December 2006.
3. Sachs SE, Sachs JD (2007) Mental health in the Millennium Development 
Goals: Not ignored. PLoS Med 4: e56. doi:10.1371/journal.pmed.0040056
4. World Health Organization (2005) Preventing chronic diseases: A vital 
investment. Geneva: World Health Organization.
5. Ebrahim S, Smeeth L (2005) Non-communicable diseases in low and 
middle-income countries: A priority or a distraction? Int J Epidemiol 34: 
961–966.
6. Strong K, Mathers C, Epping-Jordan J, Beaglehole R (2006) Preventing 
chronic disease: A priority for global health. Int J Epidemiol 35: 492–494.
7. Perel P, Casas JP, Ortiz Z, Miranda JJ (2006) Noncommunicable diseases 
and injuries in Latin America and the Caribbean: Time for action. PLoS 
Med 3: 344. doi:10.1371/journal.pmed.0030344
Citation: Miranda JJ, Patel V (2007) Mental Health in the Millennium Development 
Goals: Authors’ reply. PLoS Med 4(1): e57. doi:10.1371/journal.pmed.0040057
Copyright: © 2007 Miranda and Patel. This is an open-access article distributed 
under the terms of the Creative Commons Attribution License, which permits 
unrestricted use, distribution, and reproduction in any medium, provided the 
original author and source are credited.
Funding: The authors received no speciﬁ c funding for this article.
Competing Interests: The authors have declared that no competing interests exist.
January 2007  |  Volume 4  |  Issue 1  |  e57
